AI assistant
Sending…
Health Catalyst, Inc. — Director's Dealing 2021
Nov 15, 2021
33681_dirs_2021-11-15_9689e697-2e0c-4a84-8cfd-6514a6e4e494.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2021-11-12
Reporting Person: Hunt Bryan Truman (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-12 | Common Stock | S | 957.00 | $49.40 | Disposed | 61274.00 | Direct |
Footnotes
F1: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on September 15, 2021, in accordance with Rule 10b5-1.
More from Health Catalyst, Inc.
M&A Activity
2026
Jun 4
Proxy Solicitation & Information Statement
2026
Jun 3
Proxy Solicitation & Information Statement
2026
Jun 3
Interim / Quarterly Report
2026
May 11
Board/Management Information
2026
Apr 27
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27